Latest Attention-deficit hyperactivity disorder management Stories
PHILADELPHIA, June 20, 2011 /PRNewswire/ -- Adam Levine, lead singer of Maroon 5, is helping to raise awareness among young adults and adults about Attention-Deficit/Hyperactivity Disorder (ADHD) through a new national education campaign called "Own It" that launched today. The campaign, supported by two patient advocacy groups and made possible by Shire, aims to motivate young adults and adults who were previously diagnosed with ADHD to take charge of their health by speaking...
Study shows that preschool-age children who got less sleep were more likely to be hyperactive and inattentive in kindergartenShort sleep duration may contribute to the development or worsening of hyperactivity and inattention during early childhood, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC (APSS).Results show that less sleep in preschool-age...
Smaller brain volumes associated with severity of ADHD symptomsIn a study published today in the Clinical Neuropsychologist (e-publication ahead of print), researchers from the Kennedy Krieger Institute found differences in the brain development of preschool children with symptoms of Attention-deficit/Hyperactivity Disorder (ADHD). Results showed the region of the brain important for cognitive and motor control was smaller in these children than in typically developing children. Novel for its...
Analysis of data from two long-term studies of the impact of attention-deficit hyperactivity disorder (ADHD) on the development of psychiatric disorders in young adults confirms that ADHD alone significantly increases the risk of cigarette smoking and substance abuse in both boys and girls. The report from a team of Massachusetts General Hospital (MGH) investigators will appear in the Journal of the American Academy of Child & Adolescent Psychiatry and has been released online."Our...
SEATTLE, May 25, 2011 /PRNewswire/ -- Students with ADHD struggle with the difficult transition from high school to higher education. Studies indicate that between 50 to 95 percent(1) of college students with ADHD drop out. Edge is pleased to partner with Shire to offer a unique new scholarship program aimed at these students. Twenty-five graduating high school seniors who will start a higher education program in fall 2011 will receive a $2,000 scholarship and a full year of ADHD...
Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at the University of Pennsylvania School of Medicine and HealthCore Inc. finds they are no more likely to die from a severe cardiovascular event than those who do not take the drugs. The findings, published online in the journal Pediatrics, provide the first analysis of such...
WILMINGTON, Del., May 16, 2011 /PRNewswire/ -- Children taking medication for attention deficit hyperactivity disorder suffered no more from serious heart problems or heart-related deaths than those who were not taking ADHD medications, according to a study published online today in the journal, Pediatrics. The study, co-authored by researchers at the University of Pennsylvania and HealthCore Inc., drew data from the largest population--241,417 children and adolescents--studied to date to...
Scientists said on Monday that kids who take drugs to treat attention deficit hyperactivity disorder (ADHD) do not appear to have a higher risk of heart problems or death. Parents and doctors have been concerned in recent years about scattered reports regarding sudden deaths among children on the medications. However, researchers said that despite their limitations to study this, they call their findings reassuring. "The risk of death is certainly no higher in children who take ADHD...
FLORHAM PARK, N.J., May 9, 2011 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the publication in Pediatrics of data demonstrating the efficacy of non-stimulant KAPVAY(TM) (clonidine hydrochloride) extended-release tablets when combined with stimulant medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years). This study, the first to evaluate KAPVAY in combination with...
Difficulty with self-regulation that characterizes ADHD can extend to emotional control for someA subgroup of adults with attention-deficit hyperactivity disorder (ADHD) also exhibit excessive emotional reactions to everyday occurrences, and this combination of ADHD and emotional reactivity appears to run in families. A study from a Massachusetts General Hospital (MGH)-based research team finds that siblings of individuals with both ADHD and deficient emotional self-regulation (DESR) had a...
